On November 6, 2019, Gordon Keller, PhD, was presented with the 2019 Ogawa-Yamanaka Stem Cell Prize. A world-renowned stem cell scientist, Keller was selected for his contributions to efficient lineage-specific differentiation of human pluripotent stem cells into a myriad of cell types, enabling disease modeling and regenerative medicine approaches for many human diseases.
The Ogawa-Yamanaka Stem Cell Prize recognizes individuals whose original translational research has advanced cellular reprogramming technology for regenerative medicine. The prize was established in 2015 through a generous gift from the late Hiro and Betty Ogawa and is supported by the Gladstone Institutes. It also recognizes the importance of induced pluripotent stem cells (iPSCs), discovered by Gladstone Senior Investigator and Nobel laureate Shinya Yamanaka.
In 2019, Gladstone formed a partnership with the Cell Press group to support this important prize.
Support Discovery Science
Your gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
STAT Madness Is on, and Gladstone Is a Finalist
Article
March 1, 2021
STAT Madness Is on, and Gladstone Is a Finalist
A Gladstone discovery could be selected as the top innovation in biomedicine
Awards COVID-19 Doudna Lab Krogan Lab Ott Lab CRISPR/Gene EditingGladstone Scientist Elected into Elite Bioengineering Community
Article
February 15, 2021
Gladstone Scientist Elected into Elite Bioengineering Community
Katie Pollard is recognized by the American Institute for Medical and Biological Engineering for her pioneering creation and use of statistical research tools
Awards Data Science and Biotechnology Pollard LabGladstone Celebrates Its Core Values
Article
February 10, 2021
Gladstone Celebrates Its Core Values
Awards ceremony recognizes individual and team contributions to the Gladstone community
Awards Institutional News